In oncology today, diagnostic technology tools are key to helping scientists unlock the potential of precision medicine, so we were thrilled when Dave Messina, Chief Operating Officer of Cofactor Genomics, agreed to be a guest on The Precision Medicine podcast to talk about the importance of such tools.

The conversation with Dave was a powerful reminder of how far we’ve come—and how far we have to go—in developing and using technology to realize the promise of precision medicine in cancer.